Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder

Objectives: This extrapolation analysis qualitatively compared the efficacy and safety profile of atomoxetine from Lilly clinical trial data in 6–7-year-old patients with attention-deficit/hyperactivity disorder (ADHD) with that of published literature in 4–5-year-old patients with ADHD (two open-la...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Child Adolesc Psychopharmacol
Hlavní autoři: Upadhyaya, Himanshu, Kratochvil, Christopher, Ghuman, Jaswinder, Camporeale, Angelo, Lipsius, Sarah, D'Souza, Deborah, Tanaka, Yoko
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc. 2015
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4691648/
https://ncbi.nlm.nih.gov/pubmed/25265343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2014.0001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky